CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
CNBX Pharmaceuticals Inc.
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $197.79K
- P/E (TTM)
- –
- Dividend yield
- –
CNBX Pharmaceuticals statistics
Financials through May 31, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $240.87K | $197.05M |
| Enterprise Value | $351.38K | $106.56M |
Income (trailing twelve months)
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Revenue | $0 | $57.94M |
| Operating Income | -$429.46K | -$21.44M |
| Net Income | -$462.09K | -$22.46M |
| EBITDA | -$429.46K | -$16.91M |
Returns
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Return on Assets (ROA) | -2942.3% | -41.0% |
Balance sheet
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.49K | $62.42M |
| Total Debt | $120.00K | $120.13M |
| Net Cash (Debt) | -$110.51K | $15.68M |
| Net Cash Per Share | -$0.00 | $0.65 |
| Equity (Book Value) | -$2.66M | $48.79M |
| Book Value Per Share | -$0.00 | $1.36 |
| Tangible Book Value | -$2.66M | $23.06M |
| Working Capital | -$2.66M | $75.77M |
Financial position
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 0.00 | 3.30 |
| Quick Ratio | 0.00 | 2.39 |
Cash flow (trailing twelve months)
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$154.17K | -$12.35M |
Efficiency
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.38 |
| Revenue Per Employee | $0 | $398.96K |
| Profits Per Employee | -$9 | -$732.08K |
| Employee Count | 53,010 | 73 |
Dividends and yields
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -191.8% | -21.2% |
Shares
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 1,605,770,000 | 59,128,900 |
| Shares Change (QoQ) | 31.1% | 0.54% |
| Float | 1,605,770,000 | 48,744,500 |
| Shares Held by Insiders | 0.00% | 11.8% |
Scores
| Measure | CNBX Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | -3159.10 | 0.10 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from CNBX Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.